Susana Aznar

4.0k total citations · 1 hit paper
80 papers, 2.8k citations indexed

About

Susana Aznar is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Susana Aznar has authored 80 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cellular and Molecular Neuroscience, 30 papers in Molecular Biology and 18 papers in Neurology. Recurrent topics in Susana Aznar's work include Neuroscience and Neuropharmacology Research (25 papers), Neurotransmitter Receptor Influence on Behavior (23 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). Susana Aznar is often cited by papers focused on Neuroscience and Neuropharmacology Research (25 papers), Neurotransmitter Receptor Influence on Behavior (23 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). Susana Aznar collaborates with scholars based in Denmark, Spain and United States. Susana Aznar's co-authors include Gitte M. Knudsen, Anders B. Klein, Martin A. Santini, Tomasz Brudek, Maribel Rios, Bente Pakkenberg, Anders Ettrup, Christoffer Clemmensen, Rebecca Williamson and Tine Jess and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Neuroscience and The Journal of Physiology.

In The Last Decade

Susana Aznar

75 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood BDNF concentrations reflect brain-tissue BDNF levels across species

2010 572 citations Anders B. Klein, Rebecca Williamson et al. The International Journal of Neuropsychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susana Aznar Denmark	28	1.4k	696	535	453	436	80	2.8k
Lee Wei Lim Hong Kong	31	1.0k 0.7×	685 1.0×	576 1.1×	436 1.0×	559 1.3×	132	2.8k
Lung Yu Taiwan	29	1.1k 0.7×	505 0.7×	468 0.9×	485 1.1×	258 0.6×	85	2.5k
Thibault Renoir Australia	33	1.4k 0.9×	1.2k 1.7×	280 0.5×	527 1.2×	319 0.7×	87	2.8k
Elke Bromberg Brazil	20	1.0k 0.7×	528 0.8×	668 1.2×	312 0.7×	165 0.4×	41	2.3k
Raymond Mongeau France	27	1.5k 1.0×	858 1.2×	596 1.1×	282 0.6×	209 0.5×	59	2.8k
Janusz Moryś Poland	22	1.2k 0.8×	648 0.9×	746 1.4×	493 1.1×	213 0.5×	178	2.9k
Mal‐Soon Shin South Korea	34	705 0.5×	603 0.9×	376 0.7×	621 1.4×	400 0.9×	114	3.3k
Kebreten F. Manaye United States	31	1.6k 1.1×	771 1.1×	1.1k 2.0×	660 1.5×	847 1.9×	55	3.7k
Graham Cocks United Kingdom	10	1.5k 1.1×	676 1.0×	773 1.4×	448 1.0×	148 0.3×	16	3.5k
Deniz Yilmazer‐Hanke Germany	26	935 0.6×	418 0.6×	509 1.0×	576 1.3×	626 1.4×	74	2.4k

Countries citing papers authored by Susana Aznar

Since Specialization

Citations

This map shows the geographic impact of Susana Aznar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Aznar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Aznar more than expected).

Fields of papers citing papers by Susana Aznar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Aznar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Aznar. The network helps show where Susana Aznar may publish in the future.

Co-authorship network of co-authors of Susana Aznar

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Aznar. A scholar is included among the top collaborators of Susana Aznar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Aznar. Susana Aznar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Evans, H.E., Tyler Allison, Danielle Harrison, et al.. (2025). Design and application of a Tau seed amplification assay for screening inhibitors of Tau seeding. Alzheimer s Research & Therapy. 17(1). 214–214. 1 indexed citations

Simonsen, Anja Hviid, Kristian Winge, Lisette Salvesen, et al.. (2024). Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns. Journal of Neuroinflammation. 21(1). 317–317.

Romero, Cristina, Antonio Hernández‐Martínez, Maria Paula Santos, et al.. (2024). Differences between adolescents' and their parents' perceived benefits and barriers to actively commute to school: The PACO y PACA project. Journal of Transport & Health. 39. 101889–101889. 1 indexed citations

Palner, Mikael, Nakul Ravi Raval, Daniela Danková, et al.. (2024). Development of Peptide-Based Probes for Molecular Imaging of the Postsynaptic Density in the Brain. Journal of Medicinal Chemistry. 67(14). 11975–11988. 3 indexed citations

Farzadfard, Azad, Thomas O. Mason, Antonín Kunka, et al.. (2024). The Amplification of Alpha‐Synuclein Amyloid Fibrils is Suppressed under Fully Quiescent Conditions. Angewandte Chemie International Edition. 64(7). e202419173–e202419173. 3 indexed citations

Johansen, Annette, Vincent Beliveau, Nakul Ravi Raval, et al.. (2024). An In Vivo High-Resolution Human Brain Atlas of Synaptic Density. Journal of Neuroscience. 44(33). e1750232024–e1750232024. 3 indexed citations

Tresse, Emilie, Elham Jaberi, Erling Hu, et al.. (2023). Mitochondrial DNA damage triggers spread of Parkinson’s disease-like pathology. Molecular Psychiatry. 28(11). 4902–4914. 48 indexed citations

Batiuk, Mykhailo Y., Ignasi Oliveras, Toñi Cañete, et al.. (2023). A maturational shift in the frontal cortex synaptic transcriptional landscape underlies schizophrenia-relevant behavioural traits: A congenital rat model. European Neuropsychopharmacology. 74. 32–46. 7 indexed citations

Folke, Jonas, Isak Martinsson, Susana Aznar, et al.. (2021). DNAJB6b is Downregulated in Synucleinopathies. Journal of Parkinson s Disease. 11(4). 1791–1803. 7 indexed citations

10.

Folke, Jonas, Rasmus Rydbirk, Annemette Løkkegaard, et al.. (2019). Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease. Frontiers in Immunology. 10. 2253–2253. 27 indexed citations

11.

Klein, Anders B., Susana Aznar, Leticia Campa, et al.. (2017). Tryptophan depletion affects compulsive behaviour in rats: strain dependent effects and associated neuromechanisms. Psychopharmacology. 234(8). 1223–1236. 18 indexed citations

12.

Aznar, Susana, et al.. (2016). The 5-HT2A serotonin receptor in executive function: Implications for neuropsychiatric and neurodegenerative diseases. Neuroscience & Biobehavioral Reviews. 64. 63–82. 67 indexed citations

13.

Aznar, Susana, et al.. (2011). EL ESQUEMA DE LA ACTIVIDAD FÍSICA CON MAPAS MENTALES EN PERSONAS MAYORES. Revista iberoamericana de psicología del ejercicio y el deporte. 6(1). 31–46. 1 indexed citations

14.

Klein, Anders B., Rebecca Williamson, Martin A. Santini, et al.. (2010). Blood BDNF concentrations reflect brain-tissue BDNF levels across species. The International Journal of Neuropsychopharmacology. 14(3). 347–353. 572 indexed citations breakdown →

15.

Licht, Cecilie Löe, et al.. (2010). Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice. Neurochemistry International. 56(4). 603–610. 27 indexed citations

16.

Vinberg, Maj, et al.. (2007). Whole blood BDNF levels in healthy twins discordant for affective disorder: Association to life events and neuroticism. Journal of Affective Disorders. 108(1-2). 165–169. 28 indexed citations

17.

Christensen, Robin, et al.. (2007). Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels. Experimental Neurology. 210(1). 164–171. 90 indexed citations

18.

Sveen, Marie‐Louise, Gitte M. Knudsen, & Susana Aznar. (2004). No effect of MDMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures. Neuroscience Letters. 362(1). 6–9. 6 indexed citations

19.

Aznar, Susana & Gitte M. Knudsen. (2002). Gaba containing neurons in dorsal and median raphe nucleus project to hippocampus and medial septum/diagonal band of broca complex. 4309. 5 indexed citations

20.

Aznar, Susana & Gitte M. Knudsen. (2001). Serotonin induces a decrease of 5-HT1A immunoreactivity in organotypic hippocampal cultures. Neuroreport. 12(18). 3909–3912. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact